Oral anticoagulant treatment in management of elderly patients with atrial fibrillation [corrected]: is it beneficial or detrimental?

Edwin Setiabudi, Idrus Alwi, Siti Setiati

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

Atrial fibrillation (AF) is supraventricular tachyarrhythmia characterized by uncontrolled atrial activation, and deteriorates atrial function. In AF patients, increasing of age is related with enlarge left atrium (LA), diminished flow velocity of left atrial appendage (LAA), and spontaneously contrast echo, with other factors which are predisposition for LA thrombus. In AF patients, thromboemboli after cardioversion without anticoagulant administration is 1.5-3.0%. Elderly patient is not contraindication for anticoagulant, although higher risk for bleeding. For stroke prevention in >65 years of age whilst the patient is candidate for oral anticoagulant warfarin, it should be prescribed to reach INR 2.0-3.0. Some reports on anticoagulant evaluation (INR) and bleeding as complication of warfarin prescribed for AF treatment are not significantly different in elderly and younger patients.

Original languageEnglish
Pages (from-to)40-47
Number of pages8
JournalActa medica Indonesiana
Volume40
Issue number1
Publication statusPublished - 1 Jan 2008

Fingerprint Dive into the research topics of 'Oral anticoagulant treatment in management of elderly patients with atrial fibrillation [corrected]: is it beneficial or detrimental?'. Together they form a unique fingerprint.

Cite this